Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
In vitro and in vivo evaluation of redox-responsive sorafenib carrier nanomicelles synthesized from poly (acryic acid) -cystamine hydrochloride-D-α-tocopherol succinate
Source:
Informa UK Limited
The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer.
Source:
Elsevier BV
High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging
Source:
Wiley
CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer
Source:
Elsevier BV
A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas
Source:
Elsevier BV
Sorafenib exerts anti-glioma activity in vitro and in vivo
Source:
Elsevier BV
The adaptation of lipid nanocapsule formulations for blood administration in animals
Source:
Elsevier BV
Improving Cerebral Blood Flow Through Liposomal Delivery of Angiogenic Peptides: Potential of 18F-FDG PET Imaging in Ischemic Stroke Treatment
Source:
Society of Nuclear Medicine
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Source:
Proceedings of the National Academy of Sciences
Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide
Source:
Elsevier BV
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
Source:
Springer Nature
PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure
Source:
Elsevier BV
A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
Source:
Springer Nature
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Source:
Elsevier BV
Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model
Source:
Elsevier BV
Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro
Source:
Informa UK Limited
Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy
Source:
Future Medicine Ltd
A novel phase inversion-based process for the preparation of lipid nanocarriers.
Source:
Springer Science and Business Media LLC
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
Source:
American Association for Cancer Research (AACR)
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
Source:
Taylor & Francis
Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain
Source:
SAGE Publications
188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas
Source:
Springer Nature
Active targeting of brain tumors using nanocarriers.
Source:
Elsevier BV
Treatment of 9L Gliosarcoma in Rats by Ferrociphenol-Loaded Lipid Nanocapsules Based on a Passive Targeting Strategy via the EPR Effect
Source:
HAL CCSD
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis
Source:
Elsevier BV
Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules
Source:
Elsevier BV
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
Source:
Taylor & Francis
Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future
Source:
Springer Science and Business Media LLC
Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma
Source:
Elsevier BV
iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy
Source:
Elsevier BV
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Source:
Springer Nature
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
Source:
Taylor & Francis
Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
Source:
Springer Science and Business Media LLC
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Source:
American Association for the Advancement of Science (AAAS)
Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft
Source:
Springer Nature
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy
Source:
Springer Nature
Recent Advances in Targeted Therapy for Glioma
Source:
Bentham Science Publishers Ltd.
Toxicological Study and Efficacy of Blank and Paclitaxel-Loaded Lipid Nanocapsules After i.v. Administration in Mice
Source:
Springer Nature
Cytotoxicity and genotoxicity of lipid nanocapsules
Source:
Elsevier BV
Comparison of Sorafenib-Loaded Poly (Lactic/Glycolic) Acid and DPPC Liposome Nanoparticles in the in Vitro Treatment of Renal Cell Carcinoma
Source:
Elsevier BV
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
Source:
Oxford University Press (OUP)
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Source:
Massachusetts Medical Society
The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Source:
Elsevier BV
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy
Source:
Elsevier BV
Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Source:
Elsevier BV
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells
Source:
Elsevier BV
The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells
Source:
Elsevier BV
Management of sorafenib-related adverse events: a clinician's perspective.
Source:
Elsevier BV
Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions
Source:
Public Library of Science (PLoS)
Pharmacodynamic-Mediated Effects of the Angiogenesis Inhibitor SU5416 on the Tumor Disposition of Temozolomide in Subcutaneous and Intracerebral Glioma Xenograft Models
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
AG488 as a therapy against gliomas
Source:
Impact Journals, LLC
Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma
Source:
Ivyspring International Publisher
Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
Source:
American Association for Cancer Research (AACR)
Perfusion MRI of U87 brain tumors in a mouse model
Source:
Wiley
Lipid nanocapsules: A new platform for nanomedicine
Source:
Elsevier BV
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
Source:
Elsevier BV
Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals
Source:
Journal of Neurosurgery Publishing Group (JNSPG)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Source:
Springer Science and Business Media LLC
Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model
Source:
Springer Nature
Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
Source:
American Society of Clinical Oncology (ASCO)
Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration
Source:
Elsevier BV
Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment
Source:
Elsevier BV
Antiangiogenic Effect of Bevacizumab: Application of Arterial Spin-Labeling Perfusion MR Imaging in a Rat Glioblastoma Model
Source:
American Society of Neuroradiology (ASNR)
Linking provided by
